Abzena

Activities: Manufacturing Research & Development Pharmaceutical

Trending Articles

  1. Germfree mobile cleanroom finishes pilot programme for hospital lidocaine production Modular cleanroom expert Germfree and pharma expert ODP are now working to expand a pilot programme after a successful six months of producing medications at North Mississippi...
  2. Engineering firm Dornan makes Royal Institution of Chartered Surveyors history Dornan has been the first MEP contractor in Ireland to receive the RISE Corporate Support Scheme Badge from the Royal Institution of Chartered Surveyors
  3. Mary Marcus appointed CEO of NewAge Industries, Inc.
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    What is ISO 8 cleanroom classification? Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
  5. ContaminExpo 25–27 March 2025 | Expo | Paris, France

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Design & Build

Abzena expands biologic manufacturing site

Abzena announced an expansion in their quality control (QC) testing capabilities at their San Diego, CA, biologics development and cGMP manufacturing site
Design & Build

Abzena selects IPS for design and build of turnkey cGMP facility

Biopharma expert Abzena has chosen IPS to perform full design, construction management, and CQV services for its new monoclonal antibody (mAb) facility
Design & Build

Abzena takes modular approach to biologics suites

This expansion has been driven by an increase in customer demand for commercial-scale 2000L single-use bioreactors across a wide range of therapeutic areas
Finance

Abzena invests $60m into cGMP manufacturing capacity

The investment was reportedly driven by both existing customer requirements and by wider market demand

Richard Milbank joins Abzena
Design & Build

Abzena invests in new GMP biologics drug manufacturing plant

CEO announces US$20m investment into the expansion of biologics drug substance and ADC capabilities at new San Diego site
Pharmaceutical

Abzena and Telix sign manufacturing and bioconjugation agreement

The agreement between the developer and manufacturer of biopharmaceuticals and the radio-pharmaceuticals specialist is worth US$5.9 million
Subscribe now